Table 4.
Prevalence of cardiovascular risk factors according to socioeconomic class
| Socioeconomic class | Low | Middle | Upper middle | Upper | P |
|---|---|---|---|---|---|
| Risk factor |
N (%) |
N (%) |
N (%) |
N (%) |
|
| Hypertension |
86 (30.9) |
68 (24.5) |
55 (19.8) |
69 (24.8) |
< 0.05 |
| TC ≥ 240 mg/dL |
20 (13.0) |
11 (07.1) |
19 (12.5) |
18 (11.8) |
0.483 |
| LDL-c ≥ 160 mg/dL |
34 (22.2) |
26 (17.0) |
29 (19.1) |
32 (20.9) |
0.899 |
| Low HDL-c (mg/dL) |
72 (23.4) |
77 (25.0) |
70 (22.7) |
89 (28.9) |
0.128 |
| TG ≥ 150 mg/dL |
16 (24.6) |
16 (24.6) |
13 (20.0) |
20 (30.8) |
0.641 |
| Smoking history |
22 (50.0) |
10 (22.7) |
08 (18.2) |
04 (09.1) |
< 0.001 |
| Diabetes |
05 (14.3) |
06 (17.1) |
11 (31.4) |
13 (37.1) |
0.134 |
| Overweight |
33 (18.3) |
42 (23.3) |
43 (24.0) |
62 (34.4) |
< 0.001 |
| Obesity |
18 (15.0) |
26 (21.7) |
34 (28.3) |
42 (35.0) |
< 0.001 |
| Sedentary lifestyle |
147 (95.5) |
139 (89.1) |
132 (86.8) |
118 (77.1) |
< 0.001 |
| LVH | 47 (38.2) | 32 (26.0) | 22 (17.9) | 22 (17.9) | < 0.001 |
Hypertension: SBP ≥140 mmHg and/or DBP ≥90 mmHg or normotensive on antihypertensive medication; TC: total cholesterol; LDL-c: low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol (men, <40 mg/dL; women, <50 mg/dL); TG: triglycerides; diabetes: fasting glucose ≥126 mg/dL; overweight: BMI between 25 and 29.9 kg/m2; obesity: BMI ≥ 30.0 kg/m2; LVH, left ventricular hypertrophy (Sokolow-Lyon index ≥ 3.5 mV).